George Argyropoulos
Overview
Explore the profile of George Argyropoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samara C, Argyropoulos G, Grigoratos T, Kouras A, Manoli E, Andreadou S, et al.
Environ Sci Pollut Res Int
. 2017 Jul;
25(13):12206-12221.
PMID: 28707246
The Western Macedonian Lignite Center (WMLC) in northwestern Greece is the major lignite center in the Balkans feeding four major power plants of total power exceeding 4 GW. Concentrations of...
2.
Wood G, Chu X, Argyropoulos G, Benotti P, Rolston D, Mirshahi T, et al.
Sci Rep
. 2017 Mar;
7:43238.
PMID: 28266614
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that include steatohepatitis and fibrosis that are thought to emanate from hepatic steatosis. Few robust biomarkers or diagnostic tests have...
3.
Noel O, Still C, Argyropoulos G, Edwards M, Gerhard G
J Obes
. 2016 Mar;
2016:4390254.
PMID: 27006824
Overweight and obesity represent major risk factors for diabetes and related metabolic diseases. Obesity is associated with a chronic and progressive inflammatory response leading to the development of insulin resistance...
4.
Benotti P, Wood G, Argyropoulos G, Pack A, Keenan B, Gao X, et al.
Obesity (Silver Spring)
. 2016 Feb;
24(4):871-7.
PMID: 26880657
Objective: Obstructive sleep apnea (OSA) is common among candidates for bariatric surgery. OSA and its associated intermittent hypoxia have been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)...
5.
Petrick A, Benotti P, Wood G, Still C, Strodel W, Gabrielsen J, et al.
Obes Surg
. 2015 May;
25(12):2368-75.
PMID: 26003548
Background: Nonalcoholic fatty liver disease (NAFLD) is common in adults with extreme obesity and can impact long-term health and survival. Liver biopsy is the only accurate test for diagnosis and...
6.
Argyropoulos G
Curr Diab Rep
. 2015 Feb;
15(4):15.
PMID: 25702097
Type 2 diabetes is a chronic disease that can be treated with pharmacologic and/or lifestyle interventions, but in most cases it does not get cured. One of the few interventions,...
7.
Roesch S, Styer A, Wood G, Kosak Z, Seiler J, Benotti P, et al.
PLoS One
. 2015 Feb;
10(2):e0116928.
PMID: 25664662
Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each...
8.
Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity
Gerhard G, Benotti P, Wood G, Chu X, Argyropoulos G, Petrick A, et al.
J Obes
. 2015 Jan;
2014:368210.
PMID: 25610640
Objectives: The accumulation of lipids stored as excess triglycerides in the liver (steatosis) is highly prevalent in obesity and has been associated with several clinical characteristics, but most studies have...
9.
Huseini M, Wood G, Seiler J, Argyropoulos G, Irving B, Gerhard G, et al.
Front Med (Lausanne)
. 2015 Jan;
1:49.
PMID: 25593922
Background: Several reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and...
10.
Hayes S, Napolitano M, Lent M, Wood G, Gerhard G, Irving B, et al.
Obes Surg
. 2014 Nov;
25(1):191-4.
PMID: 25373925
Background: This study compared pre- and post-surgical data and outcomes among gastric bypass patients based on the type of insurance (Medicaid, Medicare, or private). Methods: Data were examined from 2553...